Literature DB >> 19663649

Targeting the JAK2/STAT3 axis in Alzheimer's disease.

Tomohiro Chiba1, Marina Yamada, Sadakazu Aiso.   

Abstract

BACKGROUND: Amyloid beta (Abeta) has long been implicated in the pathogenesis of Alzheimer's disease (AD). Little is known, however, about the intracellular events in neurons which lead to memory loss related to AD. Focusing on the fact that an AD-specific neuroprotective peptide named humanin (HN) inhibits AD-related neurotoxicity by activating the JAK2/STAT3 signaling axis, we recently found that age- and disease-dependent deterioration in the JAK2/STAT3 axis plays a critical role in the pathogenesis of AD. OBJECTIVE/
METHODS: Here we summarize the neuroprotective effect of HN and its derivative, named colivelin (CLN), and also review the roles of the JAK2/STAT3 axis in memory impairment related to AD. RESULTS/
CONCLUSIONS: The JAK2/STAT3 axis is a major transducer of HN-mediated neuroprotective activity. Abeta-dependent inactivation of the JAK2/STAT3 axis in hippocampal neurons causes cholinergic dysfunction via pre- and post-synaptic mechanisms, which leads to memory impairment related to AD. This provides not only a novel pathological hallmark of AD but also a novel target in AD therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19663649     DOI: 10.1517/14728220903213426

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  36 in total

1.  Humanin protects cortical neurons from ischemia and reperfusion injury by the increased activity of superoxide dismutase.

Authors:  Shen-Ting Zhao; Xiao-Tian Huang; Ce Zhang; Ya Ke
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

2.  Effects of unpaired 1 gene overexpression on the lifespan of Drosophila melanogaster.

Authors:  Alexey Moskalev; Ekaterina Proshkina; Alex Zhavoronkov; Mikhail Shaposhnikov
Journal:  BMC Syst Biol       Date:  2019-03-05

3.  Effects and mechanisms of action of SARI on androgen-independent prostate cancer (DU145) cells.

Authors:  Qian Chen; Yonghong Gu; Shengwang Zhang; Hao Deng
Journal:  Tumour Biol       Date:  2016-10-14

4.  Protective effects of humanin on okadaic Acid-induced neurotoxicities in cultured cortical neurons.

Authors:  Jinfeng Zhao; Dan Wang; Lingmin Li; Wenhui Zhao; Ce Zhang
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

Review 5.  Stressed and Inflamed, Can GSK3 Be Blamed?

Authors:  Richard S Jope; Yuyan Cheng; Jeffrey A Lowell; Ryan J Worthen; Yoel H Sitbon; Eleonore Beurel
Journal:  Trends Biochem Sci       Date:  2016-11-19       Impact factor: 13.807

6.  Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer's disease.

Authors:  Jessica Ciesler; Youssef Sari
Journal:  Open J Neurosci       Date:  2013-04-08

7.  IL-6 regulation of synaptic function in the CNS.

Authors:  Donna L Gruol
Journal:  Neuropharmacology       Date:  2014-11-22       Impact factor: 5.250

8.  Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7.

Authors:  Andrea Vergani; Sara Tezza; Francesca D'Addio; Carmen Fotino; Kaifeng Liu; Monika Niewczas; Roberto Bassi; R Damaris Molano; Sonja Kleffel; Alessandra Petrelli; Antonio Soleti; Enrico Ammirati; Maria Frigerio; Gary Visner; Fabio Grassi; Maria E Ferrero; Domenico Corradi; Reza Abdi; Camillo Ricordi; Mohamed H Sayegh; Antonello Pileggi; Paolo Fiorina
Journal:  Circulation       Date:  2012-12-18       Impact factor: 29.690

9.  Rapamycin-Sensitive Late-LTP is Enhanced in the Hippocampus of IL-6 Transgenic Mice.

Authors:  Anneke Olde Engberink; Ruben Hernandez; Pierre de Graan; Donna L Gruol
Journal:  Neuroscience       Date:  2017-11-10       Impact factor: 3.590

10.  Upregulation of Vesicular Glutamate Transporter 2 and STAT3 Activation in the Spinal Cord of Mice Receiving 3,3'-Iminodipropionitrile.

Authors:  Tomohiro Ohgomori; Ryo Yamasaki; Jun-Ichi Kira; Shozo Jinno
Journal:  Neurotox Res       Date:  2017-09-30       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.